account_balance

Investment manager · 13F filer · SEC CIK 1875197

ACT Capital Partners, L.P.

Reported value$152Mas of Sep 30, 2026
Positions56
Top 10 weight65.6%CVX alone is 10%
FiledNov 637 days after quarter end

Portfolio · as of Sep 30, 2026

Where the money is

Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.

Show the top 12 as a list
CVX Chevron Corp 10.1% KRYS Krystal Biotech, Inc. 9.2% TGTX TG Therapeutics, Inc. 8.7% XOM ExxonMobil Holdings Corp 8.4% AMZN Amazon.com Inc 7.0% ABVX Abivax S.A. 5.6% VKTX Viking Therapeutics, Inc. 4.7% SKHY SK hynix Inc. 4.2% ARWR Arrowhead Pharmaceuticals, Inc. 4.1% NKTR Nektar Therapeutics 3.6% TSLA Tesla, Inc. 3.5% CELC Celcuity Inc. 3.1%

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist